Effect of hypoprolactinaemia and hyperprolactinaemia on LH secretion, endocrine function of testes and structure of seminiferous tubules in boars. 1995

M Jedlinska, and L Rozewiecka, and A J Ziecik
Division of Reproductive Endocrinology and Pathophysiology, Polish Academy of Sciences, Olsztyn.

The influence of exogenous prolactin-induced hyperprolactinaemia and bromocriptine-induced hypoprolactinaemia on LH secretion, endocrine function of testes and the structure of seminiferous tubules was investigated in boars. Treatment with exogenous pig prolactin for 21 days (0.07 mg kg-1 day-1; n = 5) caused a significant increase in mean prolactin concentrations during the experiment (P < 0.05) and during 4 h sampling (P < 0.01). Treatment with bromocriptine (0.2 mg kg-1 per os and 0.05 mg kg-1 i.m.; n = 4) decreased mean prolactin concentrations throughout the experiment as well as during two 4 h sampling periods (P < 0.01). Treatment with exogenous prolactin decreased mean LH concentrations during the treatment (P < 0.01) and during the first 4 h sampling period (P < 0.05), but did not affect the number of pulses, pulse frequency or amplitude. Bromocriptine did not affect LH concentrations. Prolactin increased testosterone concentrations during the treatment (P < 0.01), while boars treated with bromocriptine had lower testosterone concentrations (P < 0.05) than did controls. Both exogenous prolactin and bromocriptine treatments significantly decreased oestradiol concentrations during the course of the experiment. The injections of prolactin and administration of bromocriptine caused a decrease in LH/hCG receptor concentration (P < 0.05) in the cell membrane of testes, without causing a change in binding affinity. The bromocriptine treatment caused premature release of some spermatocytes and the presence of polynucleate cells in the seminiferous tubules. In the seminiferous epithelium of hyperprolactinaemic boars, more mature cells (mainly spermatids) were released into the lumen. In tubules in which many polynucleate cells were found, considerable regression of seminiferous epithelium occurred.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011974 Receptors, LH Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis. Chorionic Gonadotropin Receptors,Human Chorionic Gonadotropin Receptors,ICSH Receptors,LH Receptors,LH-hCG Receptor,LH-hCG Receptors,Luteinizing Hormone Receptors,Lutropin Receptor,Lutropin Receptors,Receptors, Chorionic Gonadotropin,Receptors, Human Chorionic Gonadotropin,Receptors, Interstitial Cell-Stimulating Hormone,Receptors, Luteinizing Hormone,hCG Receptors,Chorionic Gonadotropin Receptor,Human Chorionic Gonadotropin Receptor,LH Receptor,Luteinizing Hormone Receptor,Receptors, ICSH,Receptors, Interstitial Cell Stimulating Hormone,Receptors, LH-hCG,Receptors, Lutropin,Receptors, hCG,hCG Receptor,Gonadotropin Receptor, Chorionic,Gonadotropin Receptors, Chorionic,Hormone Receptor, Luteinizing,Hormone Receptors, Luteinizing,LH hCG Receptor,LH hCG Receptors,Receptor, Chorionic Gonadotropin,Receptor, LH,Receptor, LH-hCG,Receptor, Luteinizing Hormone,Receptor, Lutropin,Receptor, hCG,Receptors, LH hCG
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012670 Seminiferous Epithelium The epithelium lining the seminiferous tubules composed of primary male germ cells (SPERMATOGONIA) and supporting SERTOLI CELLS. As SPERMATOGENESIS proceeds, the developing germ cells migrate toward the lumen. The adluminal compartment, the inner two thirds of the tubules, contains SPERMATOCYTES and the more advanced germ cells. Epithelium, Seminiferous,Epitheliums, Seminiferous,Seminiferous Epitheliums

Related Publications

M Jedlinska, and L Rozewiecka, and A J Ziecik
March 1973, Zeitschrift fur Anatomie und Entwicklungsgeschichte,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 1964, Medicina,
M Jedlinska, and L Rozewiecka, and A J Ziecik
May 1986, Lijecnicki vjesnik,
M Jedlinska, and L Rozewiecka, and A J Ziecik
November 2005, Toxicology and industrial health,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 1951, Revista de la Sociedad Argentina de Biologia,
M Jedlinska, and L Rozewiecka, and A J Ziecik
December 2003, Anatomy and embryology,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 1985, Applied pathology,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 2021, Archives of Razi Institute,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 1976, Andrologia,
M Jedlinska, and L Rozewiecka, and A J Ziecik
January 2011, Cell journal,
Copied contents to your clipboard!